Structural and functional properties of HIV-1ger tar sequences

Journal of Biomedical Science

Volumn 3, Issue 1, 1996, Pages 31-40

  Emiliani, Stephane ^a  

^a INSERM   (France)

Author keywords

Duplicated sequence; HIV; Transcription

Indexed keywords

TRANSACTIVATOR PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS TRANSCRIPTION;

EID: 0030045187     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253576     Document Type: Article

References (25)

1. Benkirane M, Corbeau P, Housset V, Devaux C. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J 12:4909-4921;1993;
2. Benkirane M, Hirn M, Carriére D, Devaux C. Functional epitope analysis of the human CD4 molecule: Antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of the CD4. J Virol 69:6898-6903;1995.
3. Benkirane M, Schmid-Antomarchi H, Littman DR, Hirn M, Rossi B, Devaux C. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J Virol 69:6904-6910;1995.
4. Berkhout B, Gatignol A, Silver J, Jeang KT. Efficient transactivation by the HIV-2 tat protein requires a duplicated TAR RNA structure. Nucl Acid Res 17:3551-3561;1990.
5. Berkhout B, Jeang KT. Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains. Nucl Acids Res 19:6169-6176;1991.
6. Berkhout B, Jeang KT. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol 66:139-149;1992
7. Berkhout B, Silverman R, Jeang KT. Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282;1989.
8. Braddock M, Powell R, Sutton J, Kingsman AJ, Kingsman SM. Orientation-specific cis complementation by bulge- and loop mutated human immunodeficiency virus type 1 TAR RNAs. J Virol 68:8396-8400;1994.
9. Chang YN, Jeang KT. The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of TAR2-containing LTR. Nucl Acid Res 20:5465-5472;1992.
10. Coffin JM. Genetic variation in AIDS viruses. Cell 46:1-4;1986.
11. Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, Devaux C. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol 150:290-301;1993.
12. Corbeau P, Devaux C, Kourilsky F, Chermann JC. An early post-infection signal mediated by monoclonal anti-β2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in activated peripheral blood mononuclear cells. J Virol 64:1459-1464;1990.
13. Delassus S, Meyerhans A, Cheynier R, Wain-Hobson S. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology 188:811-818;1992.
14. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis for the VAX. Nucl Acids Res 12:387-395;1984.
15. Emerman M, Guyader M, Montagnier L, Baltimore D, Muesing MA. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J 6:3755-3760;1987.
16. gag sequence of HIV-1GER, a new highly replicative and highly cytopathic HIV-1 strain of the D genotype. AIDS Res Hum Retrovir 10:1043-1045;1994.
17. Emiliani S, Delsert C, David C, Devaux C. The long terminal repeat of the human immunodeficiency virus type 1 GER isolate shows a duplication of the TAR region. AIDS Res Hum Retrovir 10:1751-1752;1994.
18. Englund G, Hoggan MD, Theodore TS, Martin MA. A novel HIV-1 isolate containing alterations affecting the NF-κB element. Virology 181:150-157;1991.
19. Garcia JA, Harrich D, Soultanakis E, Wu FK, Mitsuyasu R, Gaynor RB. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J 8:765-778;1989.
20. Garcia JA, Wu FK, Mitsuyasu R, Gaynor RB. Interactions of cellular protein involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J 6:3761-3770;1987.
21. Gaynor RB. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363;1992.
22. Gilman N. Preparation and analysis of RNA. In: Current Protocols in Molecular Biology. New York, Wiley, 1:401-478;1993.
23. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051;1982.
24. Harrich D, Garcia JA, Wu F, Mitsuyasu R, Gonzalez J, Gaynor RB. Role of Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J Virol 63:2585-2591;1989.
25. Harrich D, Hou C, Race E, Gaynor RB. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J Virol 68:5899-5910;1994.